title: Long-term MHC class II presentation of the EBV lytic protein BHRF1 by EBV latently infected b cells following capture of BHRF1 antigen.
abstract: Although T lymphocytes are considered essential for the control of EBV infection, it remains uncertain how this control occurs. We previously reported unexpected killing of EBV-transformed B-lymphoblastoid cells (LCLs) that did not express BHRF1 by CD4+ T cells specific for BHRF1, an EBV lytic cycle protein. Using LCLs transformed with an EBV mutant, in which the BHRF1 gene was deleted, we showed that killing of latently infected cells through the recognition of a protein produced during the lytic cycle is due to transfer of BHRF1 from lytically infected to latently infected cells, which occurs in culture. Accordingly, LCLs efficiently presented exogenous BHRF1 protein. Furthermore, we present evidence for persistence of captured BHRF1 Ag for several days. Due to this long-term persistence, repeated loading of suboptimal amounts of BHRF1 led to accumulation of BHRF1 Ags in LCLs and, ultimately, to their optimal recognition by BHRF1-specific CD4+ T cells. These results unveil an MHC class II-dependent pathway that could be important for the control of EBV latent infection through recognition of lytic cycle Ags.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale, Unité 601, Institut de Biologie, Nantes, France.
authors.forename: Elise
authors.initials: E
authors.lastname: Landais
authors.forename: Xavier
authors.initials: X
authors.lastname: Saulquin
authors.forename: Marc
authors.initials: M
authors.lastname: Bonneville
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Houssaint
mesh_terms: D017951:Antigen Presentation; D000956:Antigens, Viral / Q000276:immunology; D001402:B-Lymphocytes / Q000166:cytology / Q000276:immunology* / Q000821:virology; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D002461:Cell Line, Transformed; D002478:Cells, Cultured; D020031:Epstein-Barr Virus Infections / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D037182:T-Cell Antigen Receptor Specificity / Q000276:immunology; D014764:Viral Proteins / Q000276:immunology*
chemical_list: D000956:Antigens, Viral; C083278:BHRF1 protein, Human herpesvirus 4; D000949:Histocompatibility Antigens Class II; D014764:Viral Proteins